Literature DB >> 1401180

Distinction between aleukaemic prodrome of childhood acute lymphoblastic leukaemia and aplastic anaemia.

M M Reid1, G P Summerfield.   

Abstract

AIMS: To document the features of the so-called aplastic presentation of childhood acute lymphoblastic leukaemia (ALL) and to determine whether this prodrome can be distinguished from aplasia.
METHODS: The peripheral blood and bone marrow appearances of all cases of childhood ALL presenting in one health region of England in 13 years and eight months were reviewed. All cases presenting with cytopenia without circulating blasts and marrow aspirates with no infiltrate of blasts were studied in detail.
RESULTS: Four of 305 (1.3%) children presented in this way. All four had reticulin fibrosis and increased cellularity in all or part of the marrow biopsy specimen. All were girls. Three had common and one surface membrane immunoglobulin positive ALL. Reassessment of this prodrome, by combining the features of four previously reported series of similar cases with the present one, highlighted the female preponderance (19 of 22 cases), bone marrow fibrosis (10 of 11 evaluable cases), prominent bone marrow lymphocytes (14 of 22 cases) and temporary recovery (all 12 evaluable cases). Six of 14 evaluable cases had bone marrow biopsy specimen appearances of apparently uniform hypocellularity, but only one of these did not have fibrosis.
CONCLUSIONS: If, in addition to an aspirate, a bone marrow trephine biopsy is carried out the prodrome can be distinguished from aplasia in most cases. The similarity of this prodrome to aplastic anaemia is merely superficial. Clinicians and morphologists may fail to appreciate the implications of this mode of presentation if the term "aplastic" continues to be used to describe this aleukaemic prodrome of ALL.

Entities:  

Mesh:

Year:  1992        PMID: 1401180      PMCID: PMC495147          DOI: 10.1136/jcp.45.8.697

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  B-ALL without Burkitt characteristics in children.

Authors:  M M Reid
Journal:  Br J Haematol       Date:  1988-08       Impact factor: 6.998

2.  The value of roentgenography in differentiating aplastic anemia from leukemia masquerading as aplastic anemia.

Authors:  G D Shackelford; G Bloomberg; W H McAlister
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1972-11

3.  Acute childhood leukemia presenting as aplastic anemia: the response to corticosteroids.

Authors:  D K Melhorn; S Gross; A J Newman
Journal:  J Pediatr       Date:  1970-10       Impact factor: 4.406

Review 4.  Hematologic and hematopoietic consequences of B19 parvovirus infection.

Authors:  N Young
Journal:  Semin Hematol       Date:  1988-04       Impact factor: 3.851

5.  Association of cytomegalovirus infection with autoimmune type 1 diabetes.

Authors:  C Y Pak; H M Eun; R G McArthur; J W Yoon
Journal:  Lancet       Date:  1988-07-02       Impact factor: 79.321

6.  Preleukemic states in children with acute lymphoblastic leukemia.

Authors:  R H Sills; J A Stockman
Journal:  Cancer       Date:  1981-07-01       Impact factor: 6.860

  6 in total
  4 in total

1.  Severe systemic infection masking underlying childhood leukemia.

Authors:  Aruna Rajendran; Amita Trehan; Jasmina Ahluwalia; Ram Kumar Marwaha
Journal:  Indian J Hematol Blood Transfus       Date:  2012-07-25       Impact factor: 0.900

2.  Pancytopenic prodrome (pre-ALL) of acute lymphoblastic leukemia in adults: possible pathogenesis.

Authors:  S K Sohn; J S Suh; J Lee; K B Lee
Journal:  Korean J Intern Med       Date:  1998-02       Impact factor: 2.884

3.  Pancytopenia - (?) An obstacle in the diagnosis and outcome of pediatric acute lymphoblastic leukemia.

Authors:  Shruti Raja; Febe Renjitha Suman; Julius Xavier Scott; M S Latha; Aruna Rajenderan; Abhirami Ethican
Journal:  South Asian J Cancer       Date:  2015 Apr-Jun

4.  Spontaneous remission of acute lymphoblastic leukemia: A case report.

Authors:  Timm Höres; Knut Wendelin; Kerstin Schaefer-Eckart
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.